- Topic1/3
3k Popularity
14k Popularity
7k Popularity
49k Popularity
20k Popularity
- Pin
- 📢 Gate Square #MBG Posting Challenge# is Live— Post for MBG Rewards!
Want a share of 1,000 MBG? Get involved now—show your insights and real participation to become an MBG promoter!
💰 20 top posts will each win 50 MBG!
How to Participate:
1️⃣ Research the MBG project
Share your in-depth views on MBG’s fundamentals, community governance, development goals, and tokenomics, etc.
2️⃣ Join and share your real experience
Take part in MBG activities (CandyDrop, Launchpool, or spot trading), and post your screenshots, earnings, or step-by-step tutorials. Content can include profits, beginner-friendl
- 🎉 Gate Square’s "Spark Program" Surpasses 1,000 KOLs!
💥 The creator ecosystem is in full bloom!
📈 Get featured, earn rewards, and grow your influence—what are you waiting for?
💰 Cash incentives ✔️
🚀 Traffic support ✔️
👑 Exclusive verification ✔️
From 0 to 1,000 in just weeks—Gate Square is becoming the epicenter of Web3 content! ⚡
You’re not just posting content, but the next "viral opportunity"!
🌟 Join the Spark Program and kickstart your breakthrough!
👉 https://www.gate.com/announcements/article/45695
- 📢 #Gate Square Writing Contest Phase 3# is officially kicks off!
🎮 This round focuses on: Yooldo Games (ESPORTS)
✍️ Share your unique insights and join promotional interactions. To be eligible for any reward, you must also participate in Gate’s Phase 286 Launchpool, CandyDrop, or Alpha activities!
💡 Content creation + airdrop participation = double points. You could be the grand prize winner!
💰Total prize pool: 4,464 $ESPORTS
🏆 First Prize (1 winner): 964 tokens
🥈 Second Prize (5 winners): 400 tokens each
🥉 Third Prize (10 winners): 150 tokens each
🚀 How to participate:
1️⃣ Publish an
- 📢 Gate Square #TopContentChallenge# is coming! Post high-quality content and win exclusive rewards!
🌟 We will select outstanding posts for exposure, and help elevate your influence!
💡 How to Participate?
1.Add the #TopContentChallenge# tag to your post.
2.Posts must be over 60 characters and receive at least 3 interactions (Likes/Comment/Share).
3.Post may include only the #TopContentChallenge# tag.
🎁 We’ll select 1 top post to win $50 Futures Voucher every Tuesday and Thursday!
📃 High-quality posts will be shared on Gate Square and labeled as [Featured Posts]!
📌 Rewards will be distribu
Rongchang Bio responds to Pfizer's $200 million impairment of Vidisutuximab: Pfizer's conclusion is based on market competition environment.
On February 7th, Jinshi Data reported that Rongchang Biology responded to the reporter's inquiry about the devaluation of its vedolizumab (RC48) by its partner Pfizer, which amounted to a reduction of 200 million US dollars. Rongchang Biology stated that this devaluation is due to changes in the market competitive environment compared to the time of the transaction, and some indications for vedolizumab have not progressed as expected, resulting in a decrease in expected value compared to the transaction time. This conclusion was made by Pfizer based on its judgment of the market competitive environment. Previously, in August 2021, Rongchang Biology authorized the overseas rights of its HER2ADC (antibody-drug conjugate) vedolizumab to ADCleading company Seagen. In 2023, Seagen was acquired by Pfizer. Currently, Pfizer is advancing the indication of vedolizumab for urothelial carcinoma overseas.